Table 2.
Mortality and withholding of life-sustaining therapy in patients who required respiratory support at birth
| Age ≤5 years and respiratory support at birth (n=82) | All patients with respiratory support at birth (n=126) | |
| Deaths, n (%) | 48 (58.5) | 59 (46.8) |
| Country, n (%) | ||
| USA | 29 (60.4) | 39 (66.1) |
| Non-USA | 19 (39.6) | 20 (33.9) |
| Country/region, n (%) | ||
| USA | 29 (60.4) | 39 (66.1) |
| Europe | 11 (22.9) | 12 (20.3) |
| Canada | 5 (10.4) | 5 (8.5) |
| South America | 2 (4.2) | 2 (3.4) |
| Australia | 1 (2.1) | 1 (1.7) |
| Deaths with documented cause, n (%) | 30 (62.5) | 39 (66.1) |
| Respiratory failure | 24 (80.0) | 26 (66.7) |
| Cardiorespiratory arrest | 4 (13.3) | 7 (17.9) |
| Hepatic peliosis | 2 (6.7) | 4 (10.3) |
| Other | 3 (10.0) | 5 (12.8) |
| ‘Died suddenly in his sleep’, no autopsy | 0 | 1 (20.0) |
| Intra-abdominal haemorrhage (hepatic capsular rupture) | 0 | 1 (20.0) |
| Deaths without documented cause, n (%) | 18 (37.5) | 20 (33.9) |
| Life-sustaining therapy withheld among deceased patients, n/N (%) | 24/48 (50.0) | 27/59 (45.8) |
| USA | 10/24 (41.7) | 11/27 (40.7) |
| Non-USA | 14/24 (58.3) | 16/27 (59.3) |
Column header counts are the number of patients who have non-missing mortality data. For each characteristic, n refers to the number of patients with non-missing data for that characteristic.